Literature DB >> 7675913

Changes in regional cerebral blood flow on recovery from depression.

C J Bench1, R S Frackowiak, R J Dolan.   

Abstract

We have previously described focal abnormalities of regional cerebral blood flow (rCBF) in the left dorsolateral prefrontal cortex (DLPFC), anterior cingulate cortex and angular gyrus in 40 patients with major depression. We now report on the patterns of change in rCBF in a subgroup of 25 of the same patients who were rescanned following clinical remission of depression. Fifteen patients were scanned when optimally matched for drug treatment (4) or drug free on both occasions (11). The other 10 patients were fully recovered but could not be matched for drug status for clinical and ethical reasons. In a paired comparison of the same patients when ill and following recovery it was evident that remission was associated with a significant increase in rCBF in the left DLPFC and medial prefrontal cortex including anterior cingulate. Increases in rCBF in the angular gyrus were not seen when the comparison of depressed and recovered scans was matched for medication. The previously described relationship between clinical symptoms and brain perfusion in the depressed state was no longer present in the recovered state; this supports the hypothesis of state relatedness. Thus, recovery from depression is associated with increases in rCBF in the same areas in which focal decreases in rCBF are described in the depressed state in comparison with normal controls.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675913     DOI: 10.1017/s0033291700036151

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  42 in total

Review 1.  Fundamentals of neurogastroenterology.

Authors:  J D Wood; D H Alpers; P L Andrews
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Effects of medications on cerebral blood flow in late-life depression.

Authors:  Mitchell S Nobler; Kristian R Olvet; Harold A Sackeim
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

Review 3.  Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders.

Authors:  Fumiko Maeda; Alvaro Pascual-Leone
Journal:  Psychopharmacology (Berl)       Date:  2003-06-26       Impact factor: 4.530

Review 4.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

5.  Limbic activation during cue-induced cocaine craving.

Authors:  A R Childress; P D Mozley; W McElgin; J Fitzgerald; M Reivich; C P O'Brien
Journal:  Am J Psychiatry       Date:  1999-01       Impact factor: 18.112

Review 6.  Exploration and modulation of brain network interactions with noninvasive brain stimulation in combination with neuroimaging.

Authors:  Mouhsin M Shafi; M Brandon Westover; Michael D Fox; Alvaro Pascual-Leone
Journal:  Eur J Neurosci       Date:  2012-03       Impact factor: 3.386

7.  The functional neuroanatomy of geriatric depression.

Authors:  Gwenn S Smith; Elisse Kramer; Yilong Ma; Peter Kingsley; Vijay Dhawan; Thomas Chaly; David Eidelberg
Journal:  Int J Geriatr Psychiatry       Date:  2009-08       Impact factor: 3.485

8.  Dorsolateral prefrontal cortex, working memory and episodic memory processes: insight through transcranial magnetic stimulation techniques.

Authors:  Michela Balconi
Journal:  Neurosci Bull       Date:  2013-02-06       Impact factor: 5.203

Review 9.  The neurobiology of treatment response to antidepressants and mood stabilizing medications.

Authors:  L Trevor Young; David Bakish; Serge Beaulieu
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

10.  Trajectories in Cerebral Blood Flow Following Antidepressant Treatment in Late-Life Depression: Support for the Vascular Depression Hypothesis.

Authors:  Wenjing Wei; Helmet T Karim; Chemin Lin; Akiko Mizuno; Carmen Andreescu; Jordan F Karp; Charles F Reynolds; Howard J Aizenstein
Journal:  J Clin Psychiatry       Date:  2018-10-23       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.